CIK 0001728328
- Emerging growth company
Mentari Therapeutics, Inc.
Sign in to watch- Ticker
- MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 981428279
- Phone
- +1 781-887-5080
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- InMed Pharmaceuticals Inc.
- D Other Notice of Sales of Unregistered Securities
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Regulation FD disclosure
- 8-K Event Other events
- 4 Open-market buy President & CEO bought 8,800 shares at $1.73 ($15,224)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy President & CEO bought 11,400 shares at $1.75 ($19,984)
- 4 Open-market buy CFO bought 5,000 shares at $1.77 ($8,840)
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 22 of 27 · 538 filings